Cynvenio Biosystems, Inc. - Product Pipeline Analysis - New Market Report Now Available
Cynvenio Biosystems, Inc. (Cynvenio) is involved in the development and commercialization of cell isolation technologies for drug development, cancer diagnostics and biomedical research. The company's LiquidBiopsy platform is a rare cell isolation instrument designed to recover circulating tumor cells (CTCs) from the blood draw of patients with adenocarcinoma of the lung, breast, prostate, ovary, pancreas, or in colorectal or urogenital sites, necessary to support downstream molecular analysis including PCR and next generation sequencing. The LiquidBiopsy kits facilitate collection and shipping...
View full press release